Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia

Clinical trial NCT07044193 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07044193
Sponsor: Tamas Vegh, MD
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blocking Agents Residual Neuromuscular Block Reversal of Neuromuscular Blockade

Start date: 2025-06-26
Primary completion: 2028-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.